Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capability

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-2946

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capability ; volume:11 ; number:1 ; day:8 ; month:8 ; year:2019 ; pages:1-14 ; date:12.2019
Journal of cheminformatics ; 11, Heft 1 (8.8.2019), 1-14, 12.2019

Creator: Laufkötter, Oliver
Sturm, Noé
Bajorath, Jürgen
Chen, Hongming
Engkvist, Ola

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13321-019-0376-1

URN: urn:nbn:de:101:1-2019122904563396193818

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Laufkötter, Oliver
Sturm, Noé
Bajorath, Jürgen
Chen, Hongming
Engkvist, Ola
SpringerLink (Online service)

Other Objects (12)

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping

Aufsatzsammlung

Scaffold hopping in medicinal chemistry

Ionic solutes impact collagen scaffold bioactivity

Deep scaffold hopping with multimodal transformer neural networks

In silico work flow for scaffold hopping in Leishmania

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation

Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity

Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity

Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing

Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs

Scaffold hopping from amodiaquine to novel Nurr1 agonist chemotypes via microscale analogue libraries

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping

Aufsatzsammlung

Scaffold hopping in medicinal chemistry

Ionic solutes impact collagen scaffold bioactivity

Deep scaffold hopping with multimodal transformer neural networks

In silico work flow for scaffold hopping in Leishmania

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation

Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity

Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity

Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing

Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs

Scaffold hopping from amodiaquine to novel Nurr1 agonist chemotypes via microscale analogue libraries

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping

Aufsatzsammlung

Scaffold hopping in medicinal chemistry

Ionic solutes impact collagen scaffold bioactivity

Deep scaffold hopping with multimodal transformer neural networks

In silico work flow for scaffold hopping in Leishmania

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation

Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity

Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity

Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing

Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs

Scaffold hopping from amodiaquine to novel Nurr1 agonist chemotypes via microscale analogue libraries

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capability

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping

Scaffold hopping in medicinal chemistry

Ionic solutes impact collagen scaffold bioactivity

Deep scaffold hopping with multimodal transformer neural networks

In silico work flow for scaffold hopping in Leishmania

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation

Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity

Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity

Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing

Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs

Scaffold hopping from amodiaquine to novel Nurr1 agonist chemotypes via microscale analogue libraries

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping

Scaffold hopping in medicinal chemistry

Ionic solutes impact collagen scaffold bioactivity

Deep scaffold hopping with multimodal transformer neural networks

In silico work flow for scaffold hopping in Leishmania

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation

Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity

Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity

Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing

Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs

Scaffold hopping from amodiaquine to novel Nurr1 agonist chemotypes via microscale analogue libraries

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping

Scaffold hopping in medicinal chemistry

Ionic solutes impact collagen scaffold bioactivity

Deep scaffold hopping with multimodal transformer neural networks

In silico work flow for scaffold hopping in Leishmania

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation

Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity

Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity

Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing

Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs

Scaffold hopping from amodiaquine to novel Nurr1 agonist chemotypes via microscale analogue libraries

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries

Related objects

Reset password